Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 37 articles:
HTML format

Single Articles

    April 2024
  1. D'ANGELO SP, Araujo DM, Abdul Razak AR, Agulnik M, et al
    Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
    Lancet. 2024;403:1460-1471.
    PubMed     Abstract available

    January 2024
  2. WEST EE, Woodruff T, Fremeaux-Bacchi V, Kemper C, et al
    Complement in human disease: approved and up-and-coming therapeutics.
    Lancet. 2024;403:392-405.
    PubMed     Abstract available

    December 2023
    The promise of genetic therapies in sickle cell disease.
    Lancet. 2023;402:2265.

    November 2023
  4. BRADFORD DRR, Swift A, Allik M, McMahon AD, et al
    Physical health of care-experienced young children in high-income countries: a scoping review.
    Lancet. 2023;402 Suppl 1:S28.
    PubMed     Abstract available

    September 2023
  5. ROBERTS I, Jones CP
    Structural racism and iron deficiency anaemia.
    Lancet. 2023;402:834-835.

    July 2023
  6. AGARWAL N, Azad AA, Carles J, Fay AP, et al
    Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
    Lancet. 2023;402:291-303.
    PubMed     Abstract available

  7. DASHRAATH P, Lim KMX, Chin HL, Sidek A, et al
    Non-immune hydrops fetalis caused by Diamond-Blackfan anaemia and a mutation of the RPL15 gene.
    Lancet. 2023;402:141.

    June 2023
  8. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
    Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
    Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
    PubMed     Abstract available

    May 2023
  9. CONRAD N, Misra S, Verbakel JY, Verbeke G, et al
    Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
    Lancet. 2023 May 5:S0140-6736(23)00457-9. doi: 10.1016/S0140-6736(23)00457.
    PubMed     Abstract available

    April 2023
  10. SHAND AW, Kidson-Gerber GL
    Anaemia in pregnancy: a major global health problem.
    Lancet. 2023 Apr 20:S0140-6736(23)00396-3. doi: 10.1016/S0140-6736(23)00396.

  11. PASRICHA SR, Mwangi MN, Moya E, Ataide R, et al
    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00278-7. doi: 10.1016/S0140-6736(23)00278.
    PubMed     Abstract available

  12. PEPE J, Cipriani C, Colangelo L, Minisola S, et al
    Avascular necrosis in both hips in a patient with transfusion dependent beta-thalassaemia.
    Lancet. 2023;401:e19.

    January 2023
  13. VERSTOVSEK S, Gerds AT, Vannucchi AM, Al-Ali HK, et al
    Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
    Lancet. 2023;401:269-280.
    PubMed     Abstract available

  14. IKEDA K, Ueda K
    Gaining MOMENTUM against anaemic myelofibrosis.
    Lancet. 2023;401:248-249.

    November 2022
  15. MICHAEL M, Bagga A, Sartain SE, Smith RJH, et al
    Haemolytic uraemic syndrome.
    Lancet. 2022;400:1722-1740.
    PubMed     Abstract available

  16. MCDONAGH TA, Bromage DI, Cannata A
    Intravenous iron passes another endurance test in heart failure.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02180.

  17. KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
    Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
    PubMed     Abstract available

    October 2022
  18. SHIH MY, Wang JD
    Ghost cells are the spectre of fetal-maternal haemorrhage.
    Lancet. 2022;400:1223.

    September 2022
  19. VAN GALEN LS, Simsek S
    Chilling to the marrow: finding extramedullary haematopoiesis in an unusual location behind the xiphoid.
    Lancet. 2022;400:e9.

    August 2022
  20. KUO KHM, Layton DM, Lal A, Al-Samkari H, et al
    Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent alpha-thalassaemia or beta-thalassaemia: an open-label, multicentre, phase 2 study.
    Lancet. 2022;400:493-501.
    PubMed     Abstract available

    An energy booster for thalassaemic red blood cells.
    Lancet. 2022;400:470-471.

    June 2022
  22. KATTAMIS A, Kwiatkowski JL, Aydinok Y
    Lancet. 2022;399:2310-2324.
    PubMed     Abstract available

    January 2022
  23. TONELLI M, Thadhani R
    Anaemia in chronic kidney disease: what do new generation agents offer?
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00120.

  24. VIGNESHWARAN J, Kumar MS, Raghavan V, Sundari S, et al
    Seizures and sideroblastic anaemia in a patient with multidrug-resistant tuberculosis.
    Lancet. 2022;399:393.

    September 2021
  25. LICHTSINN HS, Weyand AC, McKinney ZJ, Wilson AM, et al
    Sickle cell trait: an unsound cause of death.
    Lancet. 2021;398:1128-1129.

  26. GURNARI C, Colak C, Zawit M, Maciejewski JP, et al
    Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria.
    Lancet. 2021;398:e14.

    February 2021
  27. RICHARDS T, Clevenger B, Dahly D, Besser M, et al
    Iron deficiency in PREVENTT - Authors' reply.
    Lancet. 2021;397:670.

  28. KEEGAN A, Crispin P, Ormerod A, Brown K, et al
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:669.

  29. FROESSLER B, Murphy E, Hodyl N
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:668.

  30. HOFMANN A, Gross I, Girelli D, Aapro M, et al
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:668-669.

    January 2021
  31. PASRICHA SR, Tye-Din J, Muckenthaler MU, Swinkels DW, et al
    Iron deficiency.
    Lancet. 2021;397:233-248.
    PubMed     Abstract available

  32. GUILLAUME M, Lahary A, Zourdani L, Malandain E, et al
    A painless, sudden loss of vision in sickle cell anaemia: central retinal artery occlusion.
    Lancet. 2021;397:e1.

  33. CRITCHLEY HOD, Munro MG, Shakur-Still H, Roberts I, et al
    Menstruation should not be overlooked in control of anaemia.
    Lancet. 2021;397:26.

    December 2020
  34. MUNOZ M, Gomez-Ramirez S, Rondinelli MB, Weltert L, et al
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1884.

  35. MYLES PS, Richards T, Klein A
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1883-1884.

    November 2020
  36. PONIKOWSKI P, Kirwan BA, Anker SD, McDonagh T, et al
    Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32339.
    PubMed     Abstract available

    September 2020
  37. ABRAMSON JS, Palomba ML, Gordon LI, Lunning MA, et al
    Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
    Lancet. 2020;396:839-852.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.